Sarah Johnson

Sarah Johnson, Ph.D., MBA, is a Partner at Advantary Capital Partners, with previous experience as Head of US Business Development at Oricell Therapeutics and Director of Business Development at Legend Biotech. Sarah holds a Ph.D. in Chemistry from Princeton University and an MBA from Drexel University's LeBow College of Business. Prior roles include Senior Manager of Business Development at Aro Biotherapeutics, Licensing Manager at Drexel University, and Technology Licensing Officer at the University of Pennsylvania. Sarah's academic background includes serving as a Graduate Teaching Assistant and Undergraduate Teaching Assistant at prestigious institutions, along with research assistant positions at both the University of Pennsylvania and The Wistar Institute.